Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tunç Morova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cells|March 10, 2022
Androgen Receptor-Mediated Transcription in Prostate CancerDoğancan Özturan, Tunç Morova, Nathan A Lack
Journal of Cell Science|July 28, 2021
DNA binding alters ARv7 dimer interactionsFatma Özgün, Zeynep Kaya, Tunç Morova, et al.
Nature Communications|February 13, 2020
Androgen receptor-binding sites are highly mutated in prostate cancerTunç Morova, Daniel R McNeill, Nada Lallous, et al.
Oncogene|December 12, 2019
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancerHilal Saraç, Tunç Morova, Elisabete Pires, et al.
Genome Research|June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contextsYanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
Nature Chemical Biology|April 10, 2019
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogrammingAyyub Ebrahimi, Kenan Sevinç, Gülben Gürhan Sevinç, et al.
Communications Biology|March 19, 2025
A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogrammingGülben Gürhan, Kenan Sevinç, Can Aztekin, et al.
Genome Research|May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regionsStacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Nature Communications|November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialJeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cells|March 10, 2022
Androgen Receptor-Mediated Transcription in Prostate CancerDoğancan Özturan, Tunç Morova, Nathan A Lack
Journal of Cell Science|July 28, 2021
DNA binding alters ARv7 dimer interactionsFatma Özgün, Zeynep Kaya, Tunç Morova, et al.
Nature Communications|February 13, 2020
Androgen receptor-binding sites are highly mutated in prostate cancerTunç Morova, Daniel R McNeill, Nada Lallous, et al.
Oncogene|December 12, 2019
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancerHilal Saraç, Tunç Morova, Elisabete Pires, et al.
Genome Research|June 10, 2025
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contextsYanis Zekri, Sebastian Gregoricchio, Elif Yapıcı, et al.
Nature Chemical Biology|April 10, 2019
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogrammingAyyub Ebrahimi, Kenan Sevinç, Gülben Gürhan Sevinç, et al.
Communications Biology|March 19, 2025
A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogrammingGülben Gürhan, Kenan Sevinç, Can Aztekin, et al.
Genome Research|May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regionsStacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Nature Communications|November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialJeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
Pageof 1